CXCR4 and Miyoshi myopathy: TRPV1 inhibition by AMG9810 impairs calcium homeostasis, inhibits CXCR4-mediated migration and stromal protection, synergizes with bortezomib, targets ubiquitin pathway and cytoprotective mtUPR, impairs mitochondria, destabilizes lysosome and promotes MM cell death.